DUANE HOGUE: Open Payments
NPI 1396217097 · ORANGEBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,430 in 58 payments from 17 companies in 2025. Trend: 2023 $1,549 · 2024 $1,223 · 2025 $1,430
Food & beverage: $1,353Education: $77
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $268 |
| Amgen Inc. | 9 | $199 |
| ABBVIE INC. | 8 | $197 |
| Kite Pharma, Inc. | 1 | $147 |
| Octapharma USA, Inc. | 1 | $110 |
| UCB, Inc. | 5 | $102 |
| Janssen Biotech, Inc. | 1 | $77 |
| Radius Health, Inc. | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Almatica Pharma LLC | 3 | $43 |
Products named: COSENTYX, RINVOQ, Yescarta, EVENITY, OCTAGAM IMMUNE GLOBULIN (HUMAN), Bimzelx, TREMFYA, SAPHNELO.
Industry payments across SC — which companies pay providers there.
